Circulating Tumor Cell Market is expected to grow at the CAGR of 13.8% by 2023

circulating tumor cell Market Research Report, by application (epithelial-mesenchymal transitions biomarker development), by technology – Forecast Till 2023

Major Key Players are ApoCell, Inc. (US), Biocep Ltd., Fluxion Biosciences, Inc. (US), Biocept, Inc. (US), Biofluidica Microtechnologies LLC (US), Creatv Microtech, Inc. (US), ”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, July 17, 2017 / — Market Highlights:

Circulating tumor cells is also known as tumor generating cells. They have a capability to from a tumor in different part of the body which causes cancer. The exact cause of cancer is still unknown but it is expected that different factors like genetic, exposure to radiation and numerous daily habits are also responsible for causing cancer. Global circulating tumor cells market is expecting a luxurious growth in coming future due to increasing prevalence of cancer which has increased the demand of better diagnostic test for cancer.

High cost of diagnosis and lengthy approval time both are major hurdles for the growth of this market. Global circulating tumor cell market is expected to grow at the CAGR of 13.8% during forecasted period of 2017-2023.

Request a Sample Report @

Major Key Players

• ApoCell, Inc. (US),
• Biocep Ltd. (Israel),
• Fluxion Biosciences, Inc. (US),
• Biocept, Inc. (US),
• Biofluidica Microtechnologies LLC (US),
• Creatv Microtech, Inc. (US),
• Celltraffix Inc. (US),
• Clearbridge Biomedics (Singapore),
• Janssen Diagnostics LLC (US),
• Cynvenio Biosystems, Inc. (US),
• STEMCELL Technologies, Inc. (Canada),

Epic Biosciences Inc. (US), Ikonisys, Inc. (US), IVDiagnostics, Inc. (US), ScreenCell (France), RARECELLS SAS (Italy), Epic Sciences (US), QIAGEN Hannover GmbH (Germany), Celula (US), Advanced Cell Diagnostics (US) and AdnaGen (Germany)
Increasing demand of better diagnostic test and treatment for cancer has increase competition among major companies. Major companies are using the trend of strategic alliance and acquisition to gain the market and minimize competition in the same.

ApoCell, Inc. an US headquartered company that specializes in determining effectiveness of drugs of diabetes, cancer and other diseases by measuring their effect on molecular biomarkers. This company has teamed up with cancer genetics companies for cancer profiling and therapy selection.

Epic Sciences is one of the leading company working to develop the sensitive diagnostic tests which helps to differentiate circulating tumor cells in blood. Currently this company is working on AR-V7 liquid biopsy test.

Taste the market data and market information presented through more than 49 market data tables and figures spread over 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Circulating Tumor Cell Market Research Report- Forecast To 2023

Report Details @

Regional Analysis

On regional basis global circulating tumor cell market is segmented into four major regions namely North America, Europe, Asia Pacific and Middle East and Africa. North America has the largest market in the global circulating tumor cell market. 45 % of the total global circulating tumor cell market is dominated by North America. Europe is the second largest market which is followed by Asia Pacific which is the third largest market. Asia Pacific is the fastest growing region in the global market for the same due to increasing number of cancer patients. Rapid development in the healthcare sector and increasing demand of better diagnostic test for cancer in Asia Pacific has boosted this market in this region.


Global circulating tumor cell market is segmented on the basis of application which includes epithelial- mesenchymal transitions biomarker development, prostate cancer, breast cancer, colorectal cancer and other. On the basis of technology the market is segmented into tumor cell detection, centrifugation, tumor cell enrichment and other. The tumor cell detection segment is further sub-segmented into optical methods and molecular methods.
On the basis of application, prostate cancer segment has the largest market share and it is also the fastest growing segment followed by breast cancer.

Make an Enquiry @

Browse Related Statistical Report

Asia-Pacific CBCT dental imaging market is expected to grow rapidly at a CAGR of 12.1% during the forecasted period 2016-2023. Japan commands the largest market share of Asia Pacific, CBCT dental imaging market with the market value of USD 25.6 million in 2015 and is expected to grow at a CAGR of 12.2% during the forecasted period 2016-2023.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here

Source: EIN Presswire